FOXO factors and breast cancer: outfoxing endocrine resistance.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Endocrine-Related Cancer

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/ERC-15-0461PMID 26612860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer.

  2016cited by this paper
• A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells

  2015cited by this paper
• Estrogen receptor alpha and beta in health and disease.

  2015cited by this paper
• The PAX3-FOXO1 Fusion Protein Present in Rhabdomyosarcoma Interferes with Normal FOXO Activity and the TGF-β Pathway

  2015cited by this paper
• FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells

  2015cited by this paper
• Regulation of mTORC1 by PI3K signaling.

  2015cited by this paper
• IKKβ Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis.

  2015cited by this paper
• SIRT1 Protects Against Oxidative Stress‐Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation

  2015cited by this paper
• Breast cancer: Untangling the role of progesterone receptors

  2015cited by this paper
• IKK b Enforces a LIN 28 B / TCF 7 L 2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis

  2015cited by this paper
• Cancer Stem Cell‐Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway

  2015cited by this paper
• Form and Function: how Estrogen and Progesterone Regulate the Mammary Epithelial Hierarchy

  2015cited by this paper
• Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers

  2015cited by this paper
• In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer.

  2015cited by this paper
• Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers

  2014cited by this paper
• PI3K/AKT signaling pathway and cancer: an updated review

  2014cited by this paper
• FOXO transcription factors: key regulators of cellular quality control.

  2014influential reference
• Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer

  2014cited by this paper
• Investigation of molecular alterations of AKT‐3 in triple‐negative breast cancer

  2014cited by this paper
• PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

  2014cited by this paper
• Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression.

  2014influential reference
• Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.

  2014cited by this paper
• Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells

  2014cited by this paper
• Knockdown of estrogen receptor‐α induces autophagy and inhibits antiestrogen‐mediated unfolded protein response activation, promoting ROS‐induced breast cancer cell death

  2014cited by this paper
• Discovery of 14‐3‐3 Protein–Protein Interaction Inhibitors that Sensitize Multidrug‐Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693

  2014cited by this paper
• A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes

  2014cited by this paper
• PI3K and cancer: lessons, challenges and opportunities

  2014cited by this paper
• Molecular mechanisms regulating the hormone sensitivity of breast cancer

  2014cited by this paper
• MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer

  2014cited by this paper
• Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis

  2013influential reference
• Development of PI3K inhibitors: lessons learned from early clinical trials

  2013cited by this paper
• CHIP Regulates AKT/FoxO/Bim Signaling in MCF7 and MCF10A Cells

  2013cited by this paper
• Progesterone signalling in breast cancer: a neglected hormone coming into the limelight

  2013cited by this paper
• Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

  2013cited by this paper
• The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness

  2013cited by this paper
• Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress

  2013influential reference
• Control of Foxo1 Gene Expression by Co-activator P300*

  2013cited by this paper
• Targeting nucleocytoplasmic transport in cancer therapy

  2013cited by this paper
• Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

  2012cited by this paper
• A FOXO3/IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses

  2012cited by this paper
• Sequence analysis of mutations and translocations across breast cancer subtypes

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Progesterone receptors, their isoforms and progesterone regulated transcription.

  2012cited by this paper
• Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

  2012cited by this paper
• Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment

  2012cited by this paper
• Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.

  2012cited by this paper
• Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness.

  2012cited by this paper
• Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells.

  2012cited by this paper
• Multiple modes of chromatin remodeling by Forkhead box proteins.

  2012cited by this paper
• Estrogen receptors and human disease: an update

  2012cited by this paper
• In vivo production of thiopeptide variants.

  2012cited by this paper
• Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation

  2012cited by this paper
• Abstract 3337: TGF-β from niche fibroblasts increases the stemness cancer stem cell-like side population cells in gastric cancer

  2012cited by this paper
• Mechanisms of endocrine resistance in breast cancer.

  2011cited by this paper
• ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer.

  2011cited by this paper
• Regulation of FoxO transcription factors by acetylation and protein-protein interactions.

  2011cited by this paper
• A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.

  2011cited by this paper
• ERa-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer

  2011cited by this paper
• Cancer statistics, 2011

  2011influential reference
• FoxO family members in cancer

  2011cited by this paper
• DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer.

  2011cited by this paper
• AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

  2011cited by this paper
• Molecular stratification of triple-negative breast cancers.

  2011cited by this paper
• Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.

  2011cited by this paper
• The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer

  2011cited by this paper
• Immunocytochemical Localization of Sex Steroid Hormone Receptors in Normal Human Mammary Gland

  2010cited by this paper
• FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

  2010cited by this paper
• The nuts and bolts of AGC protein kinases

  2010cited by this paper
• Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.

  2010cited by this paper
• A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates the B cell fate

  2010cited by this paper
• FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages

  2010cited by this paper
• Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH

  2010cited by this paper
• Molecular stratification of triple-negative breast cancers.

  2010cited by this paper
• Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

  2010cited by this paper
• Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.

  2009cited by this paper
• Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

  2009cited by this paper
• Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice.

  2009cited by this paper
• Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor α Transcriptional Activity in Breast Cancer Cells

  2009cited by this paper
• Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells

  2009cited by this paper
• Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a.

  2009cited by this paper
• Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.

  2009influential reference
• MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation*

  2009cited by this paper
• Profile of estrogen‐responsive genes in an estrogen‐specific mammary gland outgrowth model

  2009cited by this paper
• SIRT3 interacts with the daf-16 homolog FOXO3a in the Mitochondria, as well as increases FOXO3a Dependent Gene expression

  2008cited by this paper
• SIRT 3 interacts with the daf-16 homolog FOXO 3 a in the Mitochondria , as well as increases FOXO 3 a Dependent Gene expression

  2008cited by this paper
• Mdm2 Induces Mono-Ubiquitination of FOXO4

  2008cited by this paper
• Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis

  2008cited by this paper
• Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53.

  2008cited by this paper
• Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons

  2008cited by this paper
• ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

  2008influential reference
• 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.

  2007cited by this paper
• E2F-1 regulates expression of FOXO1 and FOXO3a.

  2007cited by this paper
• Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells

  2007cited by this paper
• IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a (PII:S0092-8674(04)00302-2)

  2007influential reference
• Progesterone signaling in mammary gland development.

  2007cited by this paper
• The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells.

  2007influential reference
• Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer

  2007cited by this paper
• FoxM1: at the crossroads of ageing and cancer.

  2007cited by this paper
• FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

  2007cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper

• DualMarker: A Multi-Source Fusion Identification Method for Prognostic Biomarkers of Breast Cancer Based on Dual-Layer Heterogeneous Network

  2025cites this paper
• Ferroptosis-related differential gene expression and immune correlates in luminal a subtype breast cancer: a prognostic model approach

  2025cites this paper
• Identification of a disulfidptosis-correlated ferroptosis prognostic model in breast cancer

  2025cites this paper
• Evaluation of the expression of LINCOO475 and FOXO1 genes as tumor suppressor genes in breast cancer: Correlation of bioinformatics tools and experimental approaches

  2024cites this paper
• MLIP and Its Potential Influence on Key Oncogenic Pathways

  2024cites this paper
• Unravelling the therapeutic potential of forkhead box proteins in breast cancer: An update (Review)

  2024cites this paper
• Hormonal regulation of miRNA during mammary gland development

  2024cites this paper
• Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions

  2024cites this paper
• High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

  2024cites this paper
• Bioinformatics and computational studies of chabamide F and chabamide G for breast cancer and their probable mechanisms of action

  2024cites this paper
• Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets

  2023cites this paper
• Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone

  2022cites this paper
• Potential roles of hsa_circ_000839 and hsa_circ_0005986 in breast cancer

  2022cites this paper
• FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression

  2022cites this paper
• A Potential Anticancer Mechanism of Finger Root (Boesenbergia rotunda) Extracts against a Breast Cancer Cell Line

  2022cites this paper
• Constructing MRNA, miRNA, circRNA and lncRNA Regulatory Network by Analysis of Microarray Data in Breast Cancer

  2021cites this paper
• FOXO1: a pivotal pioneer factor in oral squamous cell carcinoma.

  2021cites this paper
• Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis

  2021cites this paper
• Anticancer effect of the letrozole-quercetin combination mediated by FOXOs and estrogen receptors in breast cancer cells

  2021cites this paper
• β-hydroxybutyrate Alleviates Learning and Memory Impairment Through the SIRT1 Pathway in D-Galactose-Injured Mice

  2021cites this paper
• A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment

  2021cites this paper
• Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair

  2021cites this paper
• Forkhead box O1 targeting replication factor C subunit 2 expression promotes glioma temozolomide resistance and survival

  2021cites this paper
• Signalling Network of Breast Cancer Cells in Response to Progesterone

  2020cites this paper
• The Roles of FoxO Transcription Factors in Regulation of Bone Cells Function

  2020cites this paper
• Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells.

  2020cites this paper
• Identification of three miRNAs signature as a prognostic biomarker in breast cancer using bioinformatics analysis

  2020cites this paper
• The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis

  2020cites this paper
• FOXO transcription factor family in cancer and metastasis

  2020cites this paper
• Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology

  2020cites this paper
• Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.

  2020cites this paper
• FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer

  2019cites this paper
• The Progressive Journey from Ductal Carcinoma in situ into Invasive Breast Cancer: An Extensive Systematic Literature Review on Biomarkers

  2019cites this paper
• Gene expression profile analysis of ENO1 knockdown in gastric cancer cell line MGC-803

  2019cites this paper
• PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer

  2019cites this paper
• Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis

  2018cites this paper
• The Dominant Role of Forkhead Box Proteins in Cancer

  2018cites this paper
• Forkhead box O proteins: Crucial regulators of cancer EMT.

  2018cites this paper
• Transcriptional Profiling of Host Cell Responses to Virulent Haemophilus parasuis: New Insights into Pathogenesis

  2018cites this paper
• Abstract. Cancer prevention using natural micronutrition on epigenetic mechanisms primarily revolves around plant extracts. However, the role of macronutrition, including animal peptides, on epigenetic modification in cancer has been elusive. In traditional Chinese medicine, the soft-shelled turtle

  2018cites this paper
• FOXO1/3: Potential suppressors of fibrosis.

  2018cites this paper
• FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth

  2018cites this paper
• The roles of cytosolic quality control proteins, SGTA and the BAG6 complex, in disease

  2018cites this paper
• A route-based pathway analysis framework integrating mutation information and gene expression data.

  2017cites this paper
• Involvement of the FOXO6 transcriptional factor in breast carcinogenesis

  2017cites this paper
• Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs

  2017cites this paper
• Soft-shelled turtle peptide modulates microRNA profile in human gastric cancer AGS cells.

  2017cites this paper
• Navigation through inter- and intratumoral heterogeneity of endocrine resistance mechanisms in breast cancer: A potential role for Liquid Biopsies?

  2017cites this paper
• FoxO3a reactivation restores the sensitivity to the antiestrogen treatment in tamoxifen resistant breast cancer

  2017cites this paper
• Cell cycle regulated transcription: from yeast to cancer

  2016cites this paper